Literature DB >> 26328011

miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.

Ying-Fang Song1, Jing-Fang Hong2, De-Ling Liu1, Qing-An Lin1, Xiao-Peng Lan3, Guo-Xiang Lai1.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs that play key roles in cancer development and progression. Therefore, the discovery of miRNAs may provide a new and powerful tool for understanding the mechanism of carcinogenesis. In the present study, we aimed to investigate the functional significance of miR-630 and to identify its possible target genes in human non-small cell lung cancer (NSCLC). Our results showed that miR-630 was significantly down-regulated in NSCLC tissues and cell lines. The enforced expression of miR-630 was able to inhibit cell proliferation, migration, and invasion of NSCLC cells. Moreover, our results further revealed that LMO3, a nuclear LIM-only proteins, was identified as a target of miR-630. Restoration of LMO3 remarkably reversed the tumor-suppressive effects of miR-630 on cell proliferation, migration, and invasion in NSCLC cells. Therefore, we demonstrated that miR-630 suppressed the proliferation, migration, and invasion of NSCLC cells by down-regulating LMO3 expression, suggesting miR-630 as a potential therapeutic target for the treatment of human NSCLC in the future.

Entities:  

Keywords:  LMO3; Non-small cell lung cancer; invasion; miR-630; migration; proliferation

Year:  2015        PMID: 26328011      PMCID: PMC4548319     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  27 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  The oncoprotein LMO3 interacts with calcium- and integrin-binding protein CIB.

Authors:  Ling Hui; Chaoneng Ji; Bin Hui; Tongde Lv; Xiaoqin Ha; Jinsheng Yang; Wenqin Cai
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

3.  Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.

Authors:  Y Huang; A Chuang; H Hao; C Talbot; T Sen; B Trink; D Sidransky; E Ratovitski
Journal:  Cell Death Differ       Date:  2011-01-28       Impact factor: 15.828

4.  LMO3 interacts with p53 and inhibits its transcriptional activity.

Authors:  Steven Larsen; Tomoki Yokochi; Eriko Isogai; Yohko Nakamura; Toshinori Ozaki; Akira Nakagawara
Journal:  Biochem Biophys Res Commun       Date:  2009-12-06       Impact factor: 3.575

5.  Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.

Authors:  Yiping Huang; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

6.  Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.

Authors:  Jian-Jun Zhao; Peng-Jie Chen; Rui-Qin Duan; Ke-Ji Li; Yu-Zhong Wang; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 7.  MicroRNAs in cell proliferation, cell death, and tumorigenesis.

Authors:  H-W Hwang; J T Mendell
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

8.  Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R.

Authors:  Lulu Farhana; Marcia I Dawson; Farhan Murshed; Jayanta K Das; Arun K Rishi; Joseph A Fontana
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

9.  Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.

Authors:  Dake Chu; Zhengwei Zhao; Yunming Li; Jipeng Li; Jianyong Zheng; Weizhong Wang; Qingchuan Zhao; Gang Ji
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis.

Authors:  L Larzabal; A L de Aberasturi; M Redrado; P Rueda; M J Rodriguez; M E Bodegas; L M Montuenga; A Calvo
Journal:  Br J Cancer       Date:  2014-01-16       Impact factor: 7.640

View more
  14 in total

1.  High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness.

Authors:  Luiz Guilherme Darrigo Junior; Mirella Baroni; Régia Caroline Peixoto Lira; Silvia Teixeira; Paola Fernanda Fedatto; Vanessa Silva Silveira; Veridiana Kill Suazo; Luciana Chain Veronez; Rodrigo Alexandre Panepucci; David Santos Marco Antônio; José Andres Yunes; Silvia Regina Brandalise; Simone Dos Santos Aguiar; Luciano Neder; Ricardo Santos de Oliveira; Hélio Rubens Machado; Carlos Gilberto Carlotti; Luiz Gonzaga Tone; Elvis Terci Valera; Carlos Alberto Scrideli
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

2.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis.

Authors:  Yingying Chen; Ying Zhang
Journal:  Strahlenther Onkol       Date:  2022-06-24       Impact factor: 3.621

4.  Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Authors:  Emmanouil Papasavvas; Andrew V Kossenkov; Livio Azzoni; Nicola M Zetola; Agnieszka Mackiewicz; Brian N Ross; Matthew Fair; Surya Vadrevu; Doreen Ramogola-Masire; Ian Sanne; Cynthia Firnhaber; Luis J Montaner
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

5.  Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.

Authors:  Shu-Wen Chen; Tong-Bing Wang; Yu-Heng Tian; You-Guang Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression.

Authors:  Célia Dupain; Céline Gracia; Anne C Harttrampf; Julie Rivière; Birgit Geoerger; Liliane Massaad-Massade
Journal:  Oncogene       Date:  2019-09-05       Impact factor: 9.867

7.  MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.

Authors:  Ming-Jenn Chen; De-Wei Wu; Gao-Chang Wang; Yao-Chen Wang; Chi-Yi Chen; Huei Lee
Journal:  Oncotarget       Date:  2018-02-09

Review 8.  [Research Progress of Exosomes in Lung Cancer Diagnosis and Treatment].

Authors:  Hongbo Zou; Hong Wu; Chuan Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

9.  LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.

Authors:  Yan-Song Qiu; Ning-Ning Jiang; Yan Zhou; Kuai-Yun Yu; Hong-Yan Gong; Guang-Jun Liao
Journal:  Int J Mol Med       Date:  2018-02-08       Impact factor: 4.101

10.  MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.

Authors:  Wei-Xun Chen; Zhan-Guo Zhang; Ze-Yang Ding; Hui-Fang Liang; Jia Song; Xiao-Long Tan; Jing-Jing Wu; Guang-Zhen Li; Zhuo Zeng; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.